Analysis of the key themes driving private equity deal activity reveals that digitalization accounted for 2 pharmaceutical deals announced in Q2 2024, worth a total value of $2m. The $2m investment by Red Rock Equity Group in Intrepid Phoenix Ventures was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes and the Private Equity deal activity are included in GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, digitalization-related deal activity decreased by 99% in Q2 2024 compared with the previous quarter’s total of $234.6m and fell by 92% as compared to Q2 2023. Related deal volume decreased by 33% in Q2 2024 versus the previous quarter and was 33% lower than in Q2 2023.
The top-ranked financial advisors supporting these private equity deals in H1 2024 were Deloitte NSE; GREENHILL; Groupe BPCE with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these private equity deals in H1 2024 were Gomez-Acebo & Pombo Abogados; Kirkland & Ellis; Perez Llorca with 1, 1, 1 deals respectively.
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in Q2 2024 – Thematic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.